Factor-sparing use of the COX-2 inhibitor rofecoxib in haemophilic arthropathy.

Sorry, there's nothing here.

Cite this paper

@article{Bragadottir2002FactorsparingUO, title={Factor-sparing use of the COX-2 inhibitor rofecoxib in haemophilic arthropathy.}, author={Gudrun H Bragadottir and Pall T Onundarson}, journal={Haemophilia : the official journal of the World Federation of Hemophilia}, year={2002}, volume={8 6}, pages={832-3} }